estimate

NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.

Source Node:
Time Stamp: October 24, 2023 11:54 AM - Modified On: October 24, 2023 - Published By:
Source Cluster:
Republished By Plato

Summary: Progress in Neurodegenerative Research:  NKGen’s Phase 1/2a Clinical Trial for SNK01 on Track for End-of-Year Initiation SANTA ANA, Calif., Oct. 24, 2023 (Plato / Amplifi) -- Today, NKGen Biotech Inc. (Nasdaq: NKGN), a trailblazer in the field of autologous, allogeneic, and CAR-NK natural killer cell therapeutics, proudly announced the progression of its SNK01 program targeting Alzheimer’s Disease (AD), backed by the green light from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application. NKGen is gearing up to initiate its Phase 1/2a clinical trial

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Source Node:
Time Stamp: August 29, 2023 8:16 AM - Modified On: August 29, 2023 - Published By:
Source Cluster:
Republished By Plato

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Source Node:
Time Stamp: June 7, 2023 12:21 PM - Modified On: June 7, 2023 - Published By:
Source Cluster:
Republished By Plato

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating

Travelzoo META Opens for Founding Members

Source Node:
Time Stamp: May 11, 2023 7:21 AM - Modified On: May 11, 2023 - Published By:
Source Cluster:
Republished By Plato

NEW YORK/PARIS/TOKYO, May 11, 2023 - (ACN Newswire) - The future of travel is here. After months of anticipation, Travelzoo META, a members-only service offering groundbreaking Metaverse travel experiences, is now accepting its first one million Founding Members. Launched by Travelzoo® (NASDAQ: TZOO), a global Internet media company, Travelzoo META will give Founding Members the opportunity to be the first to experience travel in the Metaverse. Travelzoo META's experiences are intended to allow its members to explore hard-to-reach corners of the world, like summiting Mount Everest, or travel back in time—to

Paribus. Every Step of the Way.

Source Node:
Time Stamp: March 28, 2023 7:28 AM - Modified On: March 28, 2023 - Published By:
Source Cluster:
Republished By Plato

In this simple step-by-step article, we’ll be guiding you through the basics of using our soon to be released mainnet. We’ve worked hard to ensure it’s as intuitive and user-friendly as possible and as time goes by we’ll continue to iterate and update it with improvements. Step 1 — Get a Wallet The first step in being able to interact with the Paribus Mainnet v1 is to ensure you’ve got a crypto wallet. Our recommended wallet is MetaMask. You can download the latest version here: https://metamask.io/ For an explanation about

How Much Does Flutter App Development Cost

Source Node:
Time Stamp: February 13, 2023 1:15 AM - Modified On: February 13, 2023 - Published By:
Source Cluster:
Republished By Plato

Developing a mobile app on flutter is not the cheapest solution, just like any other mobile app development. A Flutter App would cost something from $15,000 to $300,000. Many variables depend on the application and its features. However, Let us try to break down all the elements of a Flutter App. So you can see those elements, compare them to your application, and estimate your Flutter App total cost. Are you ready? Flutter Apps Cost Elements The total cost of the Flutter App is the total cost your businesses carry

Spirit Blockchain Capital Inc. Announces setting up its first Avalanche Validator Node.

Source Node:
Time Stamp: September 7, 2022 4:14 AM - Modified On: September 7, 2022 - Published By:
Source Cluster:
Republished By Plato

VANCOUVER, British Columbia, September 06, 2022 (GLOBE NEWSWIRE) -- Spirit Blockchain Capital Inc. (the “Company” or “Spirit”), a Canadian company that offers shareholders diversified exposure to the Blockchain and crypto industry, is pleased to announce that it has made an investment in AVAX and has setup its own validator node to help secure the Avalanche network. Avalanche is one of the world’s most decentralized high-performance blockchains and continues to experience rapid growth. The Avalanche network is a Proof-of-Stake (PoS) smart contract platform that is focused on scalability and offers fast

Wikisoft Corp. Acquires Blockchain Tech Company – Etheralabs LLC

Source Node:
Time Stamp: March 1, 2022 11:07 AM - Modified On: March 1, 2022 - Published By:
Source Cluster:
Republished By Plato

San Francisco, March 1, 2022 - Wikisoft Corp. (the “Company,” “we,” and “our”) (OTCQB: WSFT) today announced that it has entered into a definitive agreement to acquire 51% of Etheralabs LLC a New York City based venture lab and ecosystem that invests in, builds, and deploys disruptive technologies across the Blockchain space. Wikisoft is using equity to fund the acquisition, thus providing the Company the optimum financial flexibility in the future. The transaction includes a global access to Etheralabs´ full stack of technologies across the Blockchain and global funding landscape.

Legacy Block (BLCK:Pancakeswap) partners with Power of One Foundation to end hunger.

Source Node:
Time Stamp: February 28, 2022 1:01 AM - Modified On: February 28, 2022 - Published By:
Source Cluster:
Republished By Plato

Santa Ana  Mayor Vincent Sarmeinto giving Andre Roberson CEO Power of One the Key to the City. Santa Ana, CA - (PLATO) - February 28, 2022 - Power of One Foundation (“POOF”) has entered into a partnership with Legacy Block (BLCK:Pancakeswap). BLCK is an operating  division of Peerless Exponential Partners, LLC (PXP). By way of the partnership  POOF will use Legacy Block’s BLCK governance token as the governance token for a series of new blockchain based projects targeted at ending hunger in the United States.  These projects will materially increase

The Problem of Time-Efficiency in dApp Development

Source Node:
Time Stamp: January 12, 2022 12:47 PM - Modified On: January 12, 2022 - Published By:
Source Cluster:
Republished By Plato

Programmers are challenged to keep up with the speed of the unfolding crypto market and the complexities of decentralization. Rapid prototyping is one of those steps in the developmental phase that makes building dApps both time-consuming and hard to complete. Opportunities for dApp developers, in a landscape that is just about to go mainstream, are hefty, and the way devs can get an advantage over their competitors is to capitalize on ways that save them time. The Languages of Blockchain Different moving parts need to be taken into consideration when